Center for Technology Transfer & Commercialization (CTTC)

Daniel Fabbri, PhD, spoke about his entrepreneurial journey from graduate studies to founding a successful health care technology company. (photo by Erin O. Smith)

Faculty member Daniel Fabbri describes entrepreneurial journey

The talk provided insights into the challenges and rewards of commercializing academic research.

Vanderbilt’s Innovation Ambassadors help their colleagues change the world

Within the intellectual powerhouse that is Vanderbilt University and Vanderbilt University Medical Center thrives a group of doctors, engineers, computer scientists and others who also are visionaries, inventors and entrepreneurs. 

Four named Master Innovators at Vanderbilt

Richard Caprioli, C. David Weaver, Susan Eagle, and Franz Baudenbacher as Master Innovators at Vanderbilt.

Shown here is the research team that discovered monoclonal antibodies that protect against COVID-19 in high-risk individuals.

COVID antibody research conducted at VUMC lands national award

A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.

From left, Jeff Balser, MD, PhD, Orrin Ingram, Jennifer Pietenpol, PhD, Mary Brock, John Brock III, John Brock IV, Major Brock, Morgan Brock, Adam Dixon, Rebecca Brock Dixon.

$10 million gift from Brock family to establish Brock Family Center for Applied Innovation

VUMC’s REDCap team helped the Washington State Department of Health ramp up its COVID-19 drive-through testing capabilities. Above, testing is performed in Everett, Washington, in March.

REDCap helps state of Washington scale up its testing capacity

Until it was eclipsed by New York in mid-April, the state of Washington had the highest absolute number of COVID-19 cases in the United States.

1 2